Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.57 |
| ▸ | ECE1 | P42892 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.51 |
| ▸ | FPR2 | P25090 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8603937 | 0.93 | ATM (0.59) | ATMKLK5 | |
| SCHEMBL8603938 | 0.93 | ATM (0.59) | ATMKLK5 | |
| Hydrochloric Acid SCHEMBL10412319 | 0.92 | ATM (0.58) | ATMKLK5 | |
| SCHEMBL11406714 | 0.89 | ATM (0.58) | ATMKLK5 | |
| SCHEMBL9301967 | 0.89 | ATM (0.58) | ATMKLK5 | |
| SCHEMBL8603038 | 0.89 | ATM (0.58) | ATMKLK5 | |
| SCHEMBL6549557 | 0.89 | ATM (0.58) | ATMKLK5 | |
| Hydrochloric Acid SCHEMBL9492789 | 0.88 | ATM (0.56) | ATMKLK5 | |
| SCHEMBL6830447 | 0.87 | ACE (0.62) | ACEECE1 | |
| SCHEMBL8605262 | 0.87 | ACE (0.62) | ACEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389240-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8361748-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20120301918-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120295304-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2012-11-22 | — | — | US | disclosed |
| EP-2180060-B1 | Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-08-29 | — | — | EP | disclosed |
| EP-2180061-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-8247193-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-2180059-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2157188-B1 | Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-2166109-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-7361458-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1587941-A4 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO KK (JP) | 2006-06-21 | — | — | EP | disclosed |
| EP-1587941-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | Ajinomoto Co., Inc. (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20050124035-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther | AJINOMOTO CO., INC. (JP) | 2005-06-09 | — | — | US | disclosed |
| WO-2004065610-A1 | METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2004-08-05 | — | — | WO | disclosed |
| EP-0297560-B1 | Imides; a process for their production and a process for the production of dipeptides using them | AJINOMOTO KK (JP) | 1998-03-04 | — | — | EP | disclosed |
| EP-0327030-B1 | Method for producing alpha-aspartylphenylalanine derivatives | AJINOMOTO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-4904802-A | Imides | AJINOMOTO CO., INC. (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0297560-A2 | Imides; a process for their production and a process for the production of dipeptides using them | Ajinomoto Co., Inc. (JP) | 1989-01-04 | — | — | EP | disclosed |
| US-4673744-A | IN ALCOHOL SOLVENT | AJINOMOTO CO., INC. (JP) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124035-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther | DNPEP, ASPH, PEPD | ACE 74/4885ECE1 125/4885ATM 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.